Byrne Asset Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.3K | Sell |
81
-8
| -9% | -$1.21K | 0.01% | 381 |
|
|
2025
Q1 | $13.4K | Sell |
89
-17
| -16% | -$2.56K | 0.01% | 380 |
|
|
2024
Q4 | $19.6K | Sell |
106
-74
| -41% | -$13.7K | 0.01% | 299 |
|
|
2024
Q3 | $35.5K | Sell |
180
-287
| -61% | -$56.5K | 0.02% | 234 |
|
|
2024
Q2 | $96.8K | Sell |
467
-67
| -13% | -$13.9K | 0.07% | 157 |
|
|
2024
Q1 | $145K | Buy |
534
+189
| +55% | +$51.2K | 0.1% | 137 |
|
|
2023
Q4 | $82.4K | Buy |
345
+4
| +1% | +$955 | 0.06% | 160 |
|
|
2023
Q3 | $67K | Sell |
341
-21
| -6% | -$4.13K | 0.06% | 172 |
|
|
2023
Q2 | $76K | Sell |
362
-11
| -3% | -$2.31K | 0.05% | 215 |
|
|
2023
Q1 | $75K | Sell |
373
-245
| -40% | -$49.3K | 0.05% | 198 |
|
|
2022
Q4 | $135K | Sell |
618
-204
| -25% | -$44.5K | 0.1% | 153 |
|
|
2022
Q3 | $162K | Sell |
822
-100
| -11% | -$19.7K | 0.12% | 124 |
|
|
2022
Q2 | $197K | Sell |
922
-192
| -17% | -$41K | 0.15% | 102 |
|
|
2022
Q1 | $316K | Sell |
1,114
-102
| -8% | -$28.9K | 0.2% | 93 |
|
|
2021
Q4 | $458K | Buy |
+1,216
| New | +$458K | 0.3% | 81 |
|